![](https://webarchive.library.unt.edu/web/20120925054518im_/http://www.fda.gov/graphics/dot_clear.gif) |
COMMITTEE NAME |
START |
DAY |
PAGES |
PDF ID |
Endocrinologic
and Metabolic Drugs Advisory Committee |
9/28/95 |
9/28/95 |
1-100 |
3107T1a.pdf |
|
|
|
101-200 |
3107T1b.pdf |
|
|
|
201 - 300 |
3107T1c.pdf |
|
|
|
301-369 |
3107T1d.pdf |
Endocrinologic
and Metabolic Drugs Advisory Committee |
9/29/95 |
9/29/95 |
238 |
3132T1.pdf |
Endocrinologic
and Metabolic Drugs Advisory Committee |
11/16/95 |
11/16/95 |
299 |
3121T1.pdf |
Page updated:
October 7, 2003
|
![](https://webarchive.library.unt.edu/web/20120925054518im_/http://www.fda.gov/graphics/dot_clear.gif) |